Researcher
Claude Libert
- Keywords (Ghent University):sepsis
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Epigenetics, Animal genetics, Autoimmunity, Clinical genetics and molecular diagnostics, Immunogenetics, Innate immunity, Transplantation immunology, Genetics, Applied immunology, Gastro-enterology and hepatology not elsewhere classified, Genome structure and regulation, Quantitative genetics, Endocrinology and metabolic diseases not elsewhere classified
- See also: Claude Libert (Flanders Institute for Biotechnology)
Affiliations
- Libert Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1996 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1996
Projects
41 - 50 of 67
- Profound study of the anti-inflammatory mechanism and therapeutic significance of GILZ in endotocemia ans sepsis.From1 Jan 2013 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Development of alphaVBeta3 nanobodies as novel cancer therapyFrom1 Jan 2013 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- Profound study of blood-brain and blood-CSF barrier disruption in systemic inflammatory disordersFrom1 Oct 2012 → 14 Jun 2013Funding: BOF - Doctoral projects
- The interactions between the brain and MMP8 and MMP3 in systemic inflammationFrom1 Jan 2012 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Profound study on the molecular basis of TNF-induced glucocorticoid resistanceFrom1 Oct 2011 → 30 Nov 2014Funding: BOF - Other initiatives, FWO fellowships
- Resolving the glucocorticoid resistance of severe asthmaFrom1 Sep 2011 → 31 Dec 2013Funding: Foundations, funds and other with scientific goal
- A detailed study of the role of SRC-1A and SRC-2 (GRP-1) in TNF-induced Glucocorticoid ResistanceFrom1 Jul 2011 → 30 Apr 2016Funding: BOF - Doctoral projects
- Circumventing the Biological Obstacles of anti-inflammatory Glucocorticoid TherapyFrom1 Jan 2011 → 31 Dec 2014Funding: SBO (Strategic basic research)
- Development of TNF as a drastic and safe anti-cancer therapyFrom1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- The development of a robust and safe anticancer therapy based on TNF and interferonFrom1 Jan 2011 → 31 Dec 2011Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 205
- The impact of hepatocyte-specific deletion of hypoxia-inducible factors on the development of polymicrobial sepsis with focus on GR and PPARα function(2023)
Authors: Tineke Vanderhaeghen, Steven Timmermans, Melanie Eggermont, Deepika Watts, Jolien Vandewalle, Charlotte Wallaeys, Louise Nuyttens, Joyca De Temmerman, Tino Hochepied, Sylviane Dewaele, et al.
- Mousepost 2.0, a major expansion of the resource(2023)
Authors: Steven Timmermans, Jolien Vandewalle, Claude Libert
Pages: 1652 - 1661 - Circulating cell-free DNA in health and disease : the relationship to health behaviours, ageing phenotypes and metabolomics(2023)
Authors: Laura Kananen, Mikko Hurme, Alexander Bürkle, Maria Moreno-Villanueva, Jürgen Bernhardt, Florence Debacq-Chainiaux, Beatrix Grubeck-Loebenstein, Marco Malavolta, Andrea Basso, Francesco Piacenza, et al.
Pages: 85 - 103 - Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF(2023)
Authors: Kai Ling Liang, Juliette Roels, Marieke Lavaert, Tom Putteman, Lena Böhme, Laurentijn Tilleman, Imke Velghe, Valentina Pegoretti, Inge Van de Walle, Stephanie Sontag, et al.
Pages: 474 - 486 - Paneth cells as the cornerstones of intestinal and organismal health : a primer(2023)
Authors: Charlotte Wallaeys, Natalia Garcia Gonzalez, Claude Libert
- Point mutation I634A in the glucocorticoid receptor causes embryonic lethality by reduced ligand binding(2022)
Authors: Steven Timmermans, Nicolette J.D. Verhoog, Kelly Van Looveren, Sylviane Dewaele, Tino Hochepied, Melanie Eggermont, Barbara Gilbert, Anne Boerema-de Munck, Tineke Vanderhaeghen, Joke Vanden Berghe, et al.
- Single-cell genome sequencing of human neurons identifies somatic point mutation and indel enrichment in regulatory elements(2022)
Authors: Lovelace J. Luquette, Michael B. Miller, Zinan Zhou, Craig L. Bohrson, Yifan Zhao, Hu Jin, Doga Gulhan, Javier Ganz, Sara Bizzotto, Samantha Kirkham, et al.
Pages: 1564 - 1571 - Novel assays monitoring direct glucocorticoid receptor protein activity exhibit high predictive power for ligand activity on endogenous gene targets(2022)
Authors: Brecht Maertens, An Staes, Claude Libert, Onno C. Meijer
- MiR-511 deficiency protects mice from experimental colitis by reducing TLR3 and TLR4 responses via WD repeat and FYVE-domain-containing protein 1(2022)
Authors: Shafaque Rahman, Jolien Vandewalle, Patricia H. P. van Hamersveld, Caroline Verseijden, Olaf Welting, Aldo Jongejan, Pierina Casanova, Sybren L. Meijer, Claude Libert, Theodorus B. M. Hakvoort, et al.
- Reprogramming of glucocorticoid receptor function by hypoxia(2022)
Authors: Tineke Vanderhaeghen, Steven Timmermans, Deepika Watts, Ville Paakinaho, Melanie Eggermont, Jolien Vandewalle, Charlotte Wallaeys, Lise Van Wyngene, Kelly Van Looveren, Louise Nuyttens, et al.
Patents
1 - 1 of 1
- Means and methods to treat inflammation (Inventor)